CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed
Drug / intervention
Perfluoropropane +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00000140
NCT00000140Phase 3Completed

The Silicone Study

National Eye Institute (NEI)·interventional·Posted Sep 24, 1999·Updated Jun 24, 2005

In Brief

A Phase 3 clinical trial evaluating Perfluoropropane, Sulfur Hexafluoride, and 1 other intervention for Proliferative Vitreoretinopathy and Retinal Detachment. Completed.

Detailed Summary

To compare, through a randomized, multicenter surgical trial, the postoperative tamponade effectiveness of intraocular silicone oil with that of an intraocular long-acting gas (initially sulfur hexafluoride \[SF 6 \], later perfluoropropane \[C 3 F 8 \]) for the management of retinal detachment complicated by proliferative vitreoretinopathy (PVR), using vitrectomy and associated techniques. To evaluate the ocular complications that result from the use of silicone oil and gas.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
Countries--
Collaborators--

Timeline

Phase 3CompletedFinished
1985198619871988198919901991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedSep 24, 1999
Enrollment StartSep 1, 1985
TodayJul 2, 2026
Posted 26.8 years ago

Interventions

Perfluoropropanedrug

Sulfur Hexafluoridedrug

Silicone Oildrug